Erection is a hemodynamic event and accordingly, erectile dysfunction (ED) is closely related with ischemic heart disease. We should con®rm that the cardiac condition of the ED patient is safe enough to perform sexual intercourse prior to beginning treatment for ED. Asymptomatic ischemic heart disease cannot be diagnosed only in an interview, but it's dif®cult to perform cardiac exercise tests on all patients complaining of ED. Therefore, screening methods to evaluate patients who should undergo exercise tests are needed. Sixty patients with erectile dysfunction participated in this study. Physical examinations, interviews, and color Doppler examinations were conducted. Chest X-rays and electrocardiograms of all patients in the resting position were obtained, as were electrocardiograms following exercise. Echocardiograms, treadmill test results, thallium exercise scintigrams, and coronary angiograms were obtained as required for diagnosis. Two patients were excluded because they had obvious arteriogenic ED due to perineal injury. Fifty-eight patients underwent Doppler evaluations of their cavernous arteries and heart exercise tests. Fourteen patients (24.1%) were diagnosed with ischemic heart disease. Although six of them had already been diagnosed with ischemic heart disease, eight were newly diagnosed by the exercise tests. Cardiovascular risk factors such as advanced age, hyperlipidemia, diabetes mellitus, hypertension, smoking, and obesity were not suf®cient predictive factors. The mean peak systolic velocity of the patients without ischemic heart disease was 34.6 cmas vs 22.0 cmas in those with ischemic heart disease. Only 3.7% of patients whose peak systolic velocity in the cavernous artery was equal to or exceeded 35 cmas had ischemic heart disease. On the other hand, 41.9% of patients with peak systolic velocity of less than 35 cmas had ischemic heart disease. The sensitivity of peak systolic velocity against ischemic heart disease was 92.9%, and speci®city was 59.1%. In ED patients, incidences of complications involving symptomatic or asymptomatic ischemic heart disease were found to be high. The peak systolic velocity in the cavernous artery is thought to be a useful predictive factor of ischemic heart disease in ED patients. When a patient reveals a peak systolic velocity of less than 35 cmas, he should undergo heart exercise tests prior to treatment of ED.
Introduction
Arterial erectile dysfunction (ED) is thought to be related to ischemic heart disease, because the most common cause of this disease is systemic atherosclerosis. Since sexual intercourse places physiological stress on the heart, it is plausible that patients with ischemic heart disease experience worsening of the disease as a result of sexual intercourse. Acute myocardial infarction, the onset of which is dif®cult to predict, 1,2 is initiated by the rupture of yellow plaques in atherosclerosis lesions in the coronary artery. 3 Aside from acute myocardial infarction, we should check for ischemic heart disease, which can be diagnosed by exercise tests prior to starting treatment for ED. It is dif®cult, however, to perform cardiac exercise tests on all patients complaining of ED. Therefore screening methods to evaluate those patients who should undergo exercise tests are needed.
Since atherosclerosis is a systemic disease, we thought we might be able to detect asymptomatic ischemic heart disease by measuring the blood¯ow in the cavernous artery. Thus we compared the color Doppler examination results of cavernous arteries and the heart exercise tests results of the ED patients.
Subjects and methods
The subjects of this study were 60 consecutive patients who visited our hospital between September 1999 and June 2000. They all received an explanation of the reason for cardiac exercise tests, and all agreed to participate in this study. We interviewed each regarding his history, especially with reference to chest pain, angina attack, ischemic heart disease, and medicines taken regularly or occasionally. In the physical examination, palpation for pulsation of arteries in the extremities was performed.
Examinations of erectile function were performed by a urologist, and heart examinations were performed by a cardiovasologist who was not noti®ed of the erectile function tests results. We performed color Doppler examination twice in each patient using prostaglandin E 1 20 mg. After a total scanning of the cavernous body, peak systolic velocities (PSV) of bilateral cavernous arteries were measured at the base of the penis. The higher of the PSV values from measurements in the two arteries was selected as the data for each patient.
We evaluated the erectile response to the intracavernous injection of 20 mg of prostaglandin E 1 , considering patient response to be normal when rigid erection occurred within 10 min after the injection (ISIR Response 3).
Chest X-rays and electrocardiograms of all patients in the resting position were obtained, as were electrocardiograms following exercise.
The ®rst exercise test was a Master's two-step test using an augmented load (double Master plus 15%). We used the diagnostic criteria of the two-step test of Master and Rosenfeld. 4 Echocardiograms, treadmill test results, and thallium exercise scintigrams were obtained as required for diagnosis. In the treadmill test, we increased the load up to the second stage of Bruce's regimen. 5 Each patient who showed an abnormal electrocardiogram after treadmill exercise underwent thallium exercise scintigrams. Those who had a large perfusion defect at scintigram underwent coronary angiograms.
In the one patient who could not do the physical exercise because of gait disturbance, a Persantine TM loaded scintigram was performed. This is a kind of thallium scintigram using vasodilating agents instead of physical exercise. Intravenous injection of Persantine TM allows vascular dilation in the normal coronary arteries, enabling us to see any regions of relatively decreased blood perfusion.
The Mann ± Whitney U-tests were used to detect possible differences in nonparametric data. Multivariate analysis of variance was used to detect differences in cardiovascular risk factors in patient groups.
Results
Two patients were excluded because they had obvious arteriogenic ED due to perineal injury. Fifty-eight patients underwent the Doppler evaluations of cavernous arteries and heart exercise tests. Their mean age was 56-y-old (range 25 ± 78).
Chest X-rays and electrocardiograms in the resting position were obtained and also electrocardiograms following exercise for these 58 patients.
For the ®nal diagnosis, we conducted echocardiograms for 24 patients, treadmill tests for 21 patients, and thallium exercise scintigrams for 18 patients. Three patients who revealed large perfusion defects in exercise scintigrams, underwent coronary angiograms both for further diagnosis and percutaneus coronary angioplasty. For one patient with gait disturbance due to spino-cerebellar degeneration, a Persantine TM loaded scintigram was performed.
Fourteen patients (24.1%) were diagnosed with ischemic heart disease. Although six of them had been already diagnosed with ischemic heart disease, eight were newly diagnosed by the exercise tests. There was no patient who lost pulsation in the peripheral arteries. Twelve (85.7%) out of 14 patients who were diagnosed with ischemic heart disease had one or more cardiovascular risk factors such as advanced age, hyperlipidemia, diabetes mellitus, hypertension, smoking, or obesity. On the other hand, 30 (68.2%) out of 44 patients diagnosed as having normal coronary circulation, had one or more cardiovascular risk factors. However, the sensitivities of these factors against ischemic heart disease were less than 50% (Table 1) . Furthermore, these cardiovascular risk factors were not statistically signi®cant predictive factors.
Three out of the 10 patients who showed a normal response to the intracavernous injection of prostaglandin E 1 were diagnosed with ischemic heart disease. Eleven out of the 48 who showed a negative response to the intracavernous injection were Cavernous artery blood¯ow and ischemic heart disease Y Kawanishi et al diagnosed with ischemic heart disease. The sensitivity of the erectile response test using intracavernous injection against ischemic heart disease was 78.6%, and speci®city was 15.9%. Cavernous arteries blood¯ow measurements by Doppler examination were taken for all patients ( Table 2 ). The mean PSV of the patients without ischemic heart disease was 34.6 cmas while that in patients with ischemic heart disease was 22.0 cmas. There was a statistically signi®cant difference between these patient groups (P`0.01).
When we compared the incidence of ischemic heart disease in the patient group with normal PSV values and in that with decreased PSV values, only 3.7% of patients whose PSV in the cavernous artery was equal to or exceeded 35 cmas had ischemic heart disease ( Table 3) . On the other hand, 41.9% of patients with PSV of less than 35 cmas had ischemic heart disease. There was a statistically signi®cant difference between these patient groups (P`0.01). The sensitivity of PSV against ischemic heart disease was 92.9%, and speci®city was 59.1%.
Discussion
Atherosclerosis is a systemic disease, so ED patients with atherosclerosis may have the same arterial lesions in their coronary artery. Therefore, it is not surprising that many arterial ED patients have ischemic heart disease. This is supported by the facts that ED and ischemic heart disease share the same risk factors, 6 ± 8 that cavernous tissues of ED patients are similar to those of atherosclerosis, 9, 10 and that erectile function shows an inverse correlation with the severity of ischemic heart disease. 11 Thus, it is no coincidence that arterial ED patients have symptomatic or asymptomatic ischemic heart disease.
The additional loading of physiological exercise on top of psychological excitement is thought to trigger acute myocardial infarction which sometimes occurs during or after sexual intercourse. 12 The physiological load imposed on the heart due to sexual intercourse in men was similar to that produced by moderate exercise. 13 But, in therapy for ED, we have paid attention only to the outcome of treatments, and we have not paid enough attention to diagnosing whether the patient's heart condition can tolerate sexual intercourse or not.
By utilizing 24-hour ambulatory electrocardiographic monitoring, Drory et al 14 demonstrated that 31% of patients with coronary artery disease that is usually silent but positive during exercise testing had evidence of myocardial ischemia during sexual intercourse. The loading imposed by sexual intercourse on the heart is thought to differ among patients, 15 and sexual intercourse performed under usual conditions with the usual partner is thought to be 5.4 metabolic equivalents (METS) at the maximum. 10 Thus, if a patient can achieve levels of 5 ± 6 METS during exercise tests without development of ischemia, the risk of ischemia during sexual intercourse is negligible. But if a patient cannot clear this level of exercise without ischemia, the patient should be treated for ischemic heart disease prior to starting treatment for ED. Hence, the tolerance level of physical exercise is important for safe sexual intercourse, and exercise testing might provide a method to screen patients who are more likely to develop cardiac ischemia with sexual intercourse.
Conti et al 6 reported that myocardial events did not increase after the treatment of ED patients who had ischemic heart disease, and concluded that we can treat ED patients who have ischemic heard disease with Sildena®l safely. However, we think the con®rmation of the absence of myocardial ischemia during exercise as strenuous as sexual intercourse is a necessary condition. In practice, though, it is very dif®cult to perform exercise tests on every ED patient. Therefore screening methods to evaluate those patients who should undergo exercise tests are needed.
We believe physical examination is important in the practice of ED, but we have not found any patient whose pulsation of peripheral arteries could not be palpated. We also think it is important to know how many cardiovascular risk factors the patient has, but, due to many exceptions, it is dif®cult to predict ischemic heart disease from cardiovascular risk factors alone. 16 In our study, cardiovascular risk factors including advanced age, hyperlipidemia, diabetes mellitus, hypertension, smoking, and obesity were not suf®cient indicators, due to their low sensitivity and low speci®city.
According to our results, the PSV value was a more reliable prospective factor against ischemic heart disease than the cardiovascular risk factors. Considering that atherosclerosis, the spread of Cavernous artery blood¯ow and ischemic heart disease Y Kawanishi et al which is systemic, is responsible for the decreased penile artery blood¯ow, it is not surprising that low PSV values can quite accurately predict the existence of ischemic heart disease. Patients with PSV of less than 35 cmas had a 41.9% incidence of ischemic heart disease. We conclude that we should perform exercise tests in patients with low PSV values, even if they had no past history of ischemic heart disease or chest symptoms. Patients with ischemic heart disease screened by PSV value and con®rmed by exercise tests should receive appropriate treatment before they receive treatment for ED.
